CME Group (CME) PT Raised to $100 at UBS, on Cyclical Upside and Higher Fees
Tweet Send to a Friend
UBS analyst Alex Kramm reiterated a Buy rating and boosted his price target on CME Group (NASDAQ: CME) to $100.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
